Delayed administration of deferoxamine reduces brain damage and promotes functional recovery after transient focal cerebral ischemia in the rat

European Journal of Neuroscience

Volumn 23, Issue 7, 2006, Pages 1757-1765

  Freret, Thomas ^a,b   Valable, Samuel ^a   Chazalviel, Laurent ^a   Saulnier, Romaric ^a   Mackenzie, Eric T ^a   Petit, Edwige ^a   Bernaudin, Myriam ^a   Boulouard, Michel ^b   Schumann Bard, Pascale ^a,b  

^a UNIVERSITÉ DE CAEN   (France)

^b CENTRE D ETUDES ET DE RECHERCHE SUR LE MÉDICAMENT DE NORMANDIE   (France)

Author keywords

Desferrioxamine; Hypoxia inducible factor 1; Sensorimotor deficit

Indexed keywords

BICARBONATE; CHLORIDE; DEFEROXAMINE MESYLATE; ERYTHROPOIETIN; GLUCOSE; GLUCOSE TRANSPORTER 1; HEMOGLOBIN; HYPOXIA INDUCIBLE FACTOR 1; IRON CHELATING AGENT; POTASSIUM; SODIUM; VASCULOTROPIN;

ANESTHESIA; ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIOXIDANT ACTIVITY; ARTICLE; BODY WEIGHT; BRAIN DAMAGE; BRAIN HYPOXIA; BRAIN ISCHEMIA; CARBON DIOXIDE TENSION; CHRONIC DRUG ADMINISTRATION; CONTROLLED STUDY; CONVALESCENCE; DRUG EFFECT; ELECTROLYTE BLOOD LEVEL; GLUCOSE BLOOD LEVEL; HEMATOCRIT; HISTOPATHOLOGY; MALE; MEAN ARTERIAL PRESSURE; MIDDLE CEREBRAL ARTERY OCCLUSION; NONHUMAN; PH; PRIORITY JOURNAL; PROPRIOCEPTION; PROTEIN EXPRESSION; RAT; RECTUM TEMPERATURE; SENSORIMOTOR INTEGRATION; STROKE; TACTILE STIMULATION; VISUAL STIMULATION; WESTERN BLOTTING;

ANIMALS; BEHAVIOR, ANIMAL; BRAIN; DEFEROXAMINE; HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT; INFARCTION, MIDDLE CEREBRAL ARTERY; IRON CHELATING AGENTS; ISCHEMIC ATTACK, TRANSIENT; MALE; MOTOR ACTIVITY; RATS; RATS, SPRAGUE-DAWLEY;

EID: 33645450194     PISSN: 0953816X     EISSN: 14609568     Source Type: Journal    
DOI: 10.1111/j.1460-9568.2006.04699.x     Document Type: Article

References (42)

1. Bederson J.B. Pitts L.H. Tsuji M. Nishimura M.C. Davis R.L. Bartkowski H. 1986 Rat middle cerebral artery occlusion: evaluation of the model and development of a neurologic examination. Stroke 17 472 476.
2. Bergeron M. Yu A.Y. Solway K.E. Semenza G.L. Sharp F.R. 1999 Induction of hypoxia-inducible factor-1 (HIF-1) and its target genes following focal ischaemia in rat brain. Eur. J. Neurosci. 11 4159 4170.
3. Bergeron M. Gidday J.M. Yu A.Y. Semenza G.L. Ferriero D.M. Sharp F.R. 2000 Role of hypoxia-inducible factor-1 in hypoxia-induced ischemic tolerance in neonatal rat brain. Ann. Neurol. 48 285 296.
4. Bernaudin M. Marti H.H. Roussel S. Divoux D. Nouvelot A. MacKenzie E.T. Petit E. 1999 A potential role for erythropoietin in focal permanent cerebral ischemia in mice. J. Cereb. Blood Flow Metab. 19 643 651.
5. Bernaudin M. Nedelec A.S. Divoux D. MacKenzie E.T. Petit E. Schumann-Bard P. 2002 Normobaric hypoxia induces tolerance to focal permanent cerebral ischemia in association with an increased expression of hypoxia-inducible factor-1 and its target genes, erythropoietin and VEGF, in the adult mouse brain. J. Cereb. Blood Flow Metab. 22 393 403.
6. Bogousslavsky J. Regli F. Uske A. 1988 Thalamic infarcts: clinical syndromes, etiology, and prognosis. Neurology 38 837 848.
7. De Bilbao F. Guarin E. Nef P. Vallet P. Giannakopoulos P. Dubois-Dauphin M. 2000 Cell death is prevented in thalamic fields but not in injured neocortical areas after permanent focal ischaemia in mice overexpressing the anti-apoptotic protein Bcl-2. Eur. J. Neurosci. 12 921 934.
8. De Ryck M. Van Reempts J. Borgers M. Wauquier A. Janssen P.A. 1989 Photochemical stroke model: flunarizine prevents sensorimotor deficits after neocortical infarcts in rats. Stroke 20 1383 1390.
9. Dihne M. Grommes C. Lutzenburg M. Witte O.W. Block F. 2002 Different mechanisms of secondary neuronal damage in thalamic nuclei after focal cerebral ischemia in rats. Stroke 33 3006 3011.
10. Gidday J.M. Fitzgibbons J.C. Shah A.R. Park T.S. 1994 Neuroprotection from ischemic brain injury by hypoxic preconditioning in the neonatal rat. Neurosci. Lett. 168 221 224.
11. Grabowski M. Brundin P. Johansson B.B. 1993 Paw-reaching, sensorimotor, and rotational behavior after brain infarction in rats. Stroke 24 889 895.
12. Halliwell B. 1989 Protection against tissue damage in vivo by desferrioxamine: what is its mechanism of action? Free Radic. Biol. Med. 7 645 651.
13. Hamrick S.E. McQuillen P.S. Jiang X. Mu D. Madan A. Ferriero D.M. 2005 A role for hypoxia-inducible factor-1alpha in desferoxamine neuroprotection. Neurosci. Lett. 379 96 100.
14. Hayashi T. Abe K. Suzuki H. Itoyama Y. 1997 Rapid induction of vascular endothelial growth factor gene expression after transient middle cerebral artery occlusion in rats. Stroke 28 2039 2044.
15. Hoe S. Rowley D.A. Halliwell B. 1982 Reactions of ferrioxamine and desferrioxamine with the hydroxyl radical. Chem. Biol. Interact. 41 75 81.
16. Hurn P.D. Koehler R.C. Blizzard K.K. Traystman R.J. 1995 Deferoxamine reduces early metabolic failure associated with severe cerebral ischemic acidosis in dogs. Stroke 26 688 694 ; discussion 694-685.
17. Iizuka H. Sakatani K. Young W. 1990 Neural damage in the rat thalamus after cortical infarcts. Stroke 21 790 794.
18. Jorgensen H.S. Nakayama H. Raaschou H.O. Vive-Larsen J. Stoier M. Olsen T.S. 1995 Outcome and time course of recovery in stroke. Part II: Time course of recovery. The Copenhagen Stroke Study. Arch. Phys. Med. Rehabil. 76 406 412.
19. Lawrence M.S. Sun G.H. Kunis D.M. Saydam T.C. Dash R. Ho D.Y. Sapolsky R.M. Steinberg G.K. 1996 Overexpression of the glucose transporter gene with a herpes simplex viral vector protects striatal neurons against stroke. J. Cereb. Blood Flow Metab. 16 181 185.
20. Longa E.Z. Weinstein P.R. Carlson S. Cummins R. 1989 Reversible middle cerebral artery occlusion without craniectomy in rats. Stroke 20 84 91.
21. Montoya C.P. Campbell-Hope L.J. Pemberton K.D. Dunnett S.B. 1991 The 'staircase test': a measure of independent forelimb reaching and grasping abilities in rats. J. Neurosci. Methods 36 219 228.
22. Moore L.E. Traystman R.J. 1994 Role of oxygen free radicals and lipid peroxidation in cerebral reperfusion injury. Adv. Pharmacol. 31 565 576.
23. Mu D. Chang Y.S. Vexler Z.S. Ferriero D.M. 2005 Hypoxia-inducible factor 1alpha and erythropoietin upregulation with deferoxamine salvage after neonatal stroke. Exp. Neurol. 195 407 415.
24. Nakamura T. Keep R.F. Hua Y. Schallert T. Hoff J.T. Xi G. 2004 Deferoxamine-induced attenuation of brain edema and neurological deficits in a rat model of intracerebral hemorrhage. J. Neurosurg. 100 672 678.
25. Oury T.D. Piantadosi C.A. Crapo J.D. 1993 Cold-induced brain edema in mice. Involvement of extracellular superoxide dismutase and nitric oxide. J. Biol. Chem. 268 15 394 15 398.
26. Palmer C. Roberts R.L. Bero C. 1994 Deferoxamine posttreatment reduces ischemic brain injury in neonatal rats. Stroke 25 1039 1045.
27. Prass K. Ruscher K. Karsch M. Isaev N. Megow D. Priller J. Scharff A. Dirnagl U. Meisel A. 2002 Desferrioxamine induces delayed tolerance against cerebral ischemia in vivo and in vitro. J. Cereb. Blood Flow Metab. 22 520 525.
28. Rose L. Bakal D.A. Fung T.S. Farn P. Weaver L.E. 1994 Tactile extinction and functional status after stroke. A preliminary investigation. Stroke 25 1973 1976.
29. Sadamoto Y. Igase K. Sakanaka M. Sato K. Otsuka H. Sakaki S. Masuda S. Sasaki R. 1998 Erythropoietin prevents place navigation disability and cortical infarction in rats with permanent occlusion of the middle cerebral artery. Biochem. Biophys. Res. Commun. 253 26 32.
30. Schallert T. Upchurch M. Wilcox R.E. Vaughn D.M. 1983 Posture-independent sensorimotor analysis of inter-hemispheric receptor asymmetries in neostriatum. Pharmacol. Biochem. Behav. 18 753 759.
31. Sharp F.R. Bernaudin M. 2004 HIF1 and oxygen sensing in the brain. Nat. Rev. Neurosci. 5 437 448.
32. Sharp F.R. Lu A. Tang Y. Millhorn D.E. 2000 Multiple molecular penumbras after focal cerebral ischemia. J. Cereb. Blood Flow Metab. 20 1011 1032.
33. Siesjo B.K. Katsura K. Zhao Q. Folbergrova J. Pahlmark K. Siesjo P. Smith M.L. 1995 Mechanisms of secondary brain damage in global and focal ischemia: a speculative synthesis. J. Neurotrauma 12 943 956.
34. STAIR 1999 Recommendations for standards regarding preclinical neuroprotective and restorative drug development. Stroke 30 2752 2758.
35. Sun Y. Jin K. Xie L. Childs J. Mao X.O. Logvinova A. Greenberg D.A. 2003 VEGF-induced neuroprotection, neurogenesis, and angiogenesis after focal cerebral ischemia. J. Clin. Invest. 111 1843 1851.
36. Tamura A. Tahira Y. Nagashima H. Kirino T. Gotoh O. Hojo S. Sano K. 1991 Thalamic atrophy following cerebral infarction in the territory of the middle cerebral artery. Stroke 22 615 618.
37. Valable S. Montaner J. Bellail A. Berezowski V. Brillault J. Cecchelli R. Divoux D. Mackenzie E.T. Bernaudin M. Roussel S. Petit E. 2005 VEGF-induced BBB permeability is associated with an MMP-9 activity increase in cerebral ischemia: both effects decreased by Ang-1. J. Cereb Blood Flow Metab. 25 1491 1504.
38. Wang G.L. Semenza G.L. 1993 Desferrioxamine induces erythropoietin gene expression and hypoxia-inducible factor 1 DNA-binding activity: implications for models of hypoxia signal transduction. Blood 82 3610 3615.
39. Wang L. Zhang Z. Wang Y. Zhang R. Chopp M. 2004 Treatment of stroke with erythropoietin enhances neurogenesis and angiogenesis and improves neurological function in rats. Stroke 35 1732 1737.
40. Warner D.S. Sheng H. Batinic-Haberle I. 2004 Oxidants, antioxidants and the ischemic brain. J. Exp. Biol. 207 3221 3231.
41. Zaman K. Ryu H. Hall D. O'Donovan K. Lin K.I. Miller M.P. Marquis J.C. Baraban J.M. Semenza G.L. Ratan R.R. 1999 Protection from oxidative stress-induced apoptosis in cortical neuronal cultures by iron chelators is associated with enhanced DNA binding of hypoxia-inducible factor-1 and ATF-1/CREB and increased expression of glycolytic enzymes, p21 (waf1/cip1), and erythropoietin. J. Neurosci. 19 9821 9830.
42. Zausinger S. Scholler K. Plesnila N. Schmid-Elsaesser R. 2003 Combination drug therapy and mild hypothermia after transient focal cerebral ischemia in rats. Stroke 34 2246 2251.